Relationship between growth hormone-IGF-I-IGFBP-3 axis and serum leptin levels with bone mass and body composition in patients with rheumatoid arthritis

Rheumatology

Volumn 44, Issue 1, 2005, Pages 120-125

  Toussirot, Éric ^a   Nguyen, N U ^a   Dumoulin, G ^a   Aubin, F ^b   Cedoz J P ^a   Wendling, D ^a  

^a UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

^b HÔPITAL SAINT JACQUES   (France)

Author keywords

Bone metabolism; Bone mineral density; Growth hormone; Insulin like growth factors; Leptin

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; GROWTH FACTOR; GROWTH HORMONE; HYDROXYCHLOROQUINE; LEPTIN; METHOTREXATE; PREDNISOLONE; SALAZOSULFAPYRIDINE; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; TIOPRONIN;

ADULT; ARTICLE; BODY COMPOSITION; BODY FAT; BONE DENSITY; BONE MASS; BONE MINERAL; CONTROLLED STUDY; CORRELATION ANALYSIS; CORTICOSTEROID THERAPY; DRUG DOSE REGIMEN; DUAL ENERGY X RAY ABSORPTIOMETRY; ECHOGRAPHY; FEMALE; FEMUR NECK; GROWTH HORMONE BLOOD LEVEL; HORMONE BLOOD LEVEL; HUMAN; INFLAMMATION; LEAN BODY WEIGHT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RADIOLOGICAL PARAMETERS; RHEUMATOID ARTHRITIS;

ADRENAL CORTEX HORMONES; ADULT; ARTHRITIS, RHEUMATOID; BODY COMPOSITION; BONE DENSITY; DENSITOMETRY, X-RAY; FEMALE; FEMUR NECK; HUMAN GROWTH HORMONE; HUMANS; INFLAMMATION MEDIATORS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; LEPTIN; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX;

EID: 12344334651     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/keh421     Document Type: Article

References (35)

1. Deodhar AA, Woolf AD. Bone mass measurement and bone metabolism in rheumatoid arthritis. Br J Rheumatol 1996;35: 309-22.
2. Kroot EJJA, Laan RFJM. Bone mass in rheumatoid arthritis. Clin Exp Rheumatol 2000;18(Suppl 21):S12-S15.
3. Sinigaglia L, Nervetti A, Mela Q et al. A multicenter cross sectional study on bone mineral density in rheumatoid arthritis. J Rheumatol 2000;27:2582-9.
4. Cortet B, Guyot MH, Solau E et al. Factors influencing bone loss in rheumatoid arthritis: a longitudinal study. Clin Exp Rheumatol 2000;18:683-90.
5. Haugeberg G, Orstavik RE, Uhlig T, Falch JA, Halse JI, Kvien TK. Bone loss in patients with rheumatoid arthritis. Results from a population-based cohort of 366 patients followed up for two years. Arthritis Rheum 2002;46:1720-8.
6. Hans D, Njeh CF, Genant HK, Meunier PJ. Quantitative ultrasound in bone status assessment. Rev Rhum (Engl Ed) 1998;65:489-98.
7. Madsen OR, Egsmose C, Hansen B, Sorensen OH. Soft tissue composition, quadriceps strength, bone quality and bone mass in rheumatoid arthritis. Clin Exp Rheumatol 1998;16:27-32.
8. Westhovens R, Nijs J, Taelman V, Dequecker J. Body composition in rheumatoid arthritis. Br J Rheumatol 1997;36:444-8.
9. Jones IJ, Clemmons DR. Insulin-like growth factors and their binding proteins: biological actions. Endocrine Rev 1995;16:3-34.
10. Garnero P, Sornay-Rendu E, Delmas PD. Low serum of IGF-I and occurrence of osteoporotic fractures in postmenopausal women. Lancet 2000;355:898-9.
11. Thomas T, Burguera B. Is leptin the link between fat and bone mass? J Bone Miner Res 2002;17:1563-9.
12. Blain H, Vuillemain A, Guillemin F et al. Serum leptin level is a predictor of bone mineral density in postmenopausal women. J Clin Endocrinol Metab 2002;87:1030-5.
13. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
14. Larsen. A. How to apply Larsen score in evaluating radiographs of rheumatoid arthritis in long term studies? J Rheumatol 1995;22: 1974-5.
15. Njeh CF, Boivin CM, Gough A et al. Evaluation of finger ultrasound in the assessment of bone status with application of rheumatoid arthritis. Osteoporosis Int 1999;9:82-90.
16. Martin JC, Munro R, Campbell MK, Reid DM. Effects of disease and corticosteroids on appendicular bone mass in postmenopausal women with rheumatoid arthritis: comparison with axial measurements. Br J Rheumatol 1997;36:43-9.
17. Sambrook P, Ral A, Hunter D, Naganathan V, Mason R, Robinson B. Osteoporosis with low dose corticosteroids: contribution of underlying disease effects and discriminatory ability of ultrasound versus bone densitometry. J Rheumatol 2001;28: 1063-7.
18. Lernbass I, Wutzl A, Grisar J et al. Quantitative ultrasound in the assessment of bone status of patients suffering from rheumatic diseases. Skeletal Radiol 2002;31:270-6.
19. Madsen OR, Sorensen OH, Egsmose C. Bone quality and bone mass as assessed by quantitative ultrasound and dual energy X-ray absorptiometry in women with rheumatoid arthritis: relationship with quadriceps strength. Ann Rheum Dis 2002;61: 325-9.
20. Wünster C, Blum WF, Schlemilch S, Ranke MB, Ziegler R. Decreased serum levels of insulin-like growth factors and IGF binding protein 3 in osteoporosis. J Intern Med 1993;234:149-55.
21. Toussirot E, Nguyen NU, Dumoulin G, Regnard J, Wendling D. Insulin-like growth factor-I and insulin-like growth factor binding protem-3 serum levels in ankylosing spondylitis. Br J Rheumatol 1998;37:1172-6.
22. Matsumoto T, Tsurumoto T. Inappropriate serum levels of IGF-I and IGFBP-3 in patients with rheumatoid arthritis. Rheumatology 2002;41:352-3.
23. Lemmey A, Maddison P, Breslin A et al. Association between insulin-like growth factor status and physical activity in rheumatoid arthritis. J Rheumatol 2001;28:29-34.
24. Ohlsson C, Bengtsson BA, Isaksson OGP, Andreassen TT, Slootweg MC. Growth hormone and bone. Endocrine Rev 1998; 19:55-79.
25. Demir H, Kelestimur F, Tunç M, Kirnap M, Ozugul Y. Hypothalamo-pituitary-adrenal axis and growth hormone axis in patients with rheumatoid arthritis. Scand J Rheumatol 1999;28:41-6.
26. Rall LC, Walsmith JM, Snydman L et al. Cachexia in rheumatoid arthritis is not explained by decreased growth hormone secretion. Arthritis Rheum 2002;46:2574-7.
27. Elhassan AM, Adem A, Suliman IA, Mustafa A, Lindgren JU. Prolactin, growth hormone, and IGF-I in ankles and plasma of adjuvant arthritic rats. Scand J Rheumatol 1999;28:368-73.
28. Borges MH, Pinto AC, DiNinno FB et al. IGF-I levels rise and GH responses to GHRH decrease during long-term prednisone treatment in man. J Endocrinol Invest 1999;22:12-17.
29. Prumel MF, Wiersinga WM, Osting H, Endert E. The effects of long term prednisone treatment on growth hormone and insulin-like growth factor-I. J Endocrinol Invest 1996;19:620-3.
30. Thomas T, Burguera B, Melton J et al. Relationship of serum leptin levels with body composition and sex steroid and insulin levels in men and women. Metabolism 2000;49:1278-84.
31. Ruhl CE, Everhart JE. Relationship of serum leptin concentration with bone mineral density in the United States population. J Bone Miner Res 2002;17:1896-903.
32. Nyomba BLG, Johnson M, Berard L, Murphy LJ. Relationship between serum leptin and the insulin-like growth factor-I system in humans. Metabolism 1999;48:840-4.
33. Matarese G, La Cava A, Sanna V et al. Balancing susceptibility to infection and autoimmunity: a role for leptin? Trends Immunol 2002;23:182-7.
34. Anders HJ, Rihl M, Heufelder A, Loch O, Schattenkirchner M. Leptin serum levels are not correlated with disease activity in patients with rheumatoid arthritis. Metabolism 1999;48:745-8.
35. Bokarewa M, Bokarew D, Hultgren O, Tarkowski A. Leptin consumption in the inflamed joints of patients with rheumatoid arthritis. Ann Rheum Dis 2003;62:952-6.